Biomaterial‐Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation
Small · 2026-08 · 22 (45)
DOI: 10.1002/smll.74313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 24.06.2026. Verfasst von Binbin Ji und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Electroporation, Biocompatible Materials, Neoplasms, Gene Editing. Die Arbeit nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai key specialty construction project.
Abstract (Originalsprache)
Electroporation has evolved from a membrane‐permeabilization method into a versatile therapeutic platform for intracellular delivery, locoregional tumor intervention, and bioelectrically regulated treatment. Depending on pulse intensity and duration, electroporation operates in two distinct modes: reversible electroporation (RE), which transiently permeabilizes the plasma membrane to enable delivery of nucleic acids, proteins, and small molecules while preserving cell viability, and irreversible electroporation (IRE), which causes permanent membrane damage for non‐thermal tissue ablation. Increasingly, the therapeutic scope of electroporation is being expanded through integration with biomaterials, including nanocarriers, hydrogels, soft conductors, and micro/nanoengineered bioelectronic interfaces. These material‐assisted strategies improve cargo protection, field confinement, local retention, tissue conformity, and spatiotemporal control, thereby extending electroporation beyond conventional transfection toward gene editing, engineered cell manufacturing, electrochemotherapy, tumor ablation, immune modulation, and transdermal or localized delivery. In this Review, we summarize the biophysical principles of RE and IRE, discuss how biomaterials reshape electroporation performance across therapeutic settings, compare the design logic of major biomaterial‐assisted electroporation platforms, and highlight key translational challenges, including pulse‐material compatibility, manufacturing scalability, in vivo dosimetry, and regulatory complexity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
- Department of Radiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
- Department of Orthopaedics, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
ORCID-Profile: Jingfeng Li, Wenguo Cui, Zhongmin Wang
Förderung
- National Natural Science Foundation of China
- Shanghai key specialty construction project
Zitieren
APA
Ji, B., Wu, Z., Jiang, Y., Liu, X., Li, J., Xu, F., Li, C., Shan, Q., Wang, Z., Wang, J., Huang, W., Zhuang, Y., Cui, W., & Wang, Z. (2026). Biomaterial‐Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation. Small, 22(45). https://doi.org/10.1002/smll.74313
Vancouver
Ji B, Wu Z, Jiang Y, Liu X, Li J, Xu F, et al. Biomaterial‐Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation. Small. 2026;22(45). doi:10.1002/smll.74313
BibTeX
@article{Ji2026,
author = {Ji, Binbin and Wu, Zhuozhuo and Jiang, Yuyue and Liu, Xiaoyu and Li, Jingfeng and Xu, Fengkuo and Li, Chaojie and Shan, Qungang and Wang, Ziyin and Wang, Junhao and Huang, Wei and Zhuang, Yaping and Cui, Wenguo and Wang, Zhongmin},
title = {Biomaterial‐Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation},
journal = {Small},
year = {2026},
volume = {22},
number = {45},
doi = {10.1002/smll.74313}
}
EUVIMED